Liver transplantation in children

TY - JOUR

T1 - Liver transplantation in children

AU - Muiesan, P

AU - Vergani, D

AU - Mieli-Vergani, G

PY - 2007/2

Y1 - 2007/2

N2 - Liver transplantation (LT) is now a standard treatment for children with end-stage liver disease with excellent 1- and 5-year survival. This has been achieved through improvement of surgical techniques and anti-rejection treatment and management. The donor pool for children has been extended by the use of cut-down, split, living-related and, recently, non-heart-beating donor and isolated hepatocyte transplantation. Though the majority of transplanted children enjoy an excellent quality of life, there remain a high number of possible complications, including short-term primary non-function, vascular and biliary problems, bowel perforation, severe rejection, infection, hypertension and long-term renal impairment, chronic rejection, de novo autoimmunity, lymphoproliferative disease and cancer, most of which are related to anti-rejection drug toxicity. Hence, the focus of research for paediatric LT should be induction of tolerance, avoiding long-term immunosuppression and its toxicity. (c) 2006 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved

AB - Liver transplantation (LT) is now a standard treatment for children with end-stage liver disease with excellent 1- and 5-year survival. This has been achieved through improvement of surgical techniques and anti-rejection treatment and management. The donor pool for children has been extended by the use of cut-down, split, living-related and, recently, non-heart-beating donor and isolated hepatocyte transplantation. Though the majority of transplanted children enjoy an excellent quality of life, there remain a high number of possible complications, including short-term primary non-function, vascular and biliary problems, bowel perforation, severe rejection, infection, hypertension and long-term renal impairment, chronic rejection, de novo autoimmunity, lymphoproliferative disease and cancer, most of which are related to anti-rejection drug toxicity. Hence, the focus of research for paediatric LT should be induction of tolerance, avoiding long-term immunosuppression and its toxicity. (c) 2006 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved

U2 - 10.1016/j.jhep.2006.11.006

DO - 10.1016/j.jhep.2006.11.006

M3 - Literature review

SN - 1600-0641

VL - 46

SP - 340

EP - 348

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 2

ER -